Skip to main content
Premium Trial:

Request an Annual Quote

ATCC, CDC, Thermo Fisher Partner to Bring HIV Drug Resistance Assay to Resource-Poor Countries

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific to bring a rapid, cost-effective PCR-based method of monitoring HIV drug resistance to resource-limited countries, ATCC said today.

Specifically, ATCC and CDC have partnered to scale up and distribute the kit to World Health Organization-designated and CDC-supported genotyping laboratories established through the US President's Emergency Plan for AIDS Relief (PEPFAR).

The ATCC HIV-1 Drug Resistance Genotyping Kit was optimized for off-the-shelf detection of specific HIV-1 genomic mutations that confer resistance to certain anti-retroviral therapies. In addition, the kit can be used to sequence and genotype certain regions of the HIV-1 genome that are targeted by ARVs and are the principle locations of ARV-resistance mutations.

In addition, ATCC said that the kit as been optimized for sample collection methods most often used in developing countries, such as dried blood spots. Furthermore, ATCC said that it is leveraging its expertise in global cold-chain distribution of biological materials to supply the temperature-sensitive reagents under stable conditions.

"More than 35 million people worldwide are living with HIV/AIDS, and drug resistance continues to confront people living with HIV," Dan Didier, director of public health in Thermo Fisher's Life Sciences Solutions group, said in a statement. "Through our partnership with the CDC and ATCC we have been able to supply components for a surveillance system to understand the spread of drug-resistant HIV throughout the African continent."

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.